Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Blood|April 23, 2017
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon responseJared A Wallace, Dominique A Kagele, Anna M Eiring, et al.The New England Journal of Medicine|June 4, 2020
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in ChildrenVéronique Minard-Colin, Anne Aupérin, Marta Pillon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2021
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II TrialG A Amos Burke, Veronique Minard-Colin, Anne Aupérin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.The Journal of Clinical Investigation|July 26, 2014
Proteasome function is required for platelet productionDallas S Shi, Matthew C P Smith, Robert A Campbell, et al.Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.Blood|April 12, 2012
Zebrafish screen identifies novel compound with selective toxicity against leukemiaSuzanne Ridges, Will L Heaton, Deepa Joshi, et al.JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.Leukemia|April 17, 2020
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targetingDomenico Viola, Ada Dona, Enrico Caserta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.Pageof 5